Is the text of JIS T 0993-1 free?

No. The text is sold by Japanese Industrial Standards Committee. This page gives the code, title, edition and scope only.

Metric	Value	Period
Total Revenue	9999999999999	FY2099
Net Income	-8888888888	FY2099
Earnings Per Share	123.456789	FY2099
Gross Profit	7777777777	FY2099
Operating Income	6666666666	FY2099

Metric	Value	Period
Total Revenue	9999999999999	FY2099
Net Income	-8888888888	FY2099
Earnings Per Share	123.456789	FY2099
Gross Profit	7777777777	FY2099
Operating Income	6666666666	FY2099

Back

JIS T 0993-1 (2020)

Q: What is JIS T 0993-1?

JIS T 0993-1 (edition 2020) is Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process (JIS version). general principles of biological evaluation within risk management, device categories by contact type and duration, and biological safety risk assessment. Identical adoption of the international standard.

Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process (JIS version)

Japanese Industrial Standards CommitteeNational standardBiocompatibilityMedical devicesHigh confidenceLast verified October 4, 2026

general principles of biological evaluation within risk management, device categories by contact type and duration, and biological safety risk assessment. Identical adoption of the international standard.

The text of this standard is sold by Japanese Industrial Standards Committee and is not reproduced here. This page gives the code, edition, scope and what each market says about it.

Recognition by market

Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts

No market listing is published yet.

Testing requirements that cite it

Open the market page and its pathway pages for the full requirement, protocol and report content

Japan

Biological safety evaluation of the final deviceBiocompatibility · Not stated

Not legal or regulatory advice. Check the current official rules before you act. Parts of the approvals data are official open data reused under open licences. Data sources.